Mitomics MDNA Moves Into Liquid Biopsy Market With New Prostate Cancer Test Premium The company has rededicated itself to a fully blood-based test pipeline, with its next assays focused on women's health, including endometriosis and ovarian, uterine, and cervical cancers. In Brief This Week: Mitomics, Sterling Pathology National Laboratories; J. Craig Venter Institute, CLC Bio; LabCorp NEW YORK (GenomeWeb News) – Mitomics said this week it has entered into a sales and marketing deal with Sterling Pathology National Laboratories covering Mitomics' Prostate Core Mitomic Test. Dx Focus: Akonni TruDiagnosis Studies; Spartan Bio CYP2C19 Test; Mitomics Prostate Cancer Assay Premium Akonni Biosystems this week announced the results of three preclinical studies in support of the efficacy of its TruDiagnosis molecular diagnostics platform and TruArray tests, and said that the platform is now ready for expanded, multi-site clin CML HealthCare to Offer Mitomics Prostate Test in Canada NEW YORK (GenomeWeb News) – CML HealthCare today said that it has licensed exclusive rights to offer Mitomics' prostate cancer test in Canada. Mitomics Inks Sales and Marketing Deal with LabCorp NEW YORK (GenomeWeb News) – Mitomics today announced a deal with Laboratory Corporation of America to offer Mitomics' molecular prostate cancer test. Sep 17, 2012 Mitomics Realigns, Eliminates Eight Positions Feb 16, 2012 Dx Focus: LabMD to Distribute Mitomics' Prostate Test; Lab21's NSCLC Companion Dx Test Premium Feb 14, 2012 Mitomics Inks US Marketing Deal for Prostate Test Nov 2, 2011 Bostwick Marketing Mitomics' Prostate Cancer Dx in the US May 19, 2011 QDx Pathology to Market Mitomics' PCR-Based Mitochondrial DNA Prostate Cancer Test in US Premium May 19, 2011 Mitomics, QDx Ink Development, Marketing Pact Mar 31, 2011 Mitomics Launches Test for Detecting Prostate Cancer from Negative Biopsies Premium Jul 16, 2010 People In The News: Jul 16, 2010 Jul 15, 2010 Mitochondrial Genomics Firm Eyes MDx for Cancer Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.